These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7746176)

  • 21. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral 17beta-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size.
    Tangney CC; Mosca LJ; Otvos JD; Rosenson RS
    Atherosclerosis; 2001 Apr; 155(2):425-30. PubMed ID: 11254913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study.
    Greendale GA; Espeland M; Slone S; Marcus R; Barrett-Connor E;
    Arch Intern Med; 2002 Mar; 162(6):665-72. PubMed ID: 11911720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.
    Orr-Walker BJ; Evans MC; Clearwater JM; Horne A; Grey AB; Reid IR
    Arch Intern Med; 2000 Jul; 160(14):2161-6. PubMed ID: 10904459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
    Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Haines CJ; Chan TY; Li M; Sham A
    Menopause; 2003; 10(4):352-61. PubMed ID: 12851519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal treatment and psychological function during the menopausal transition: an evaluation of the effects of conjugated estrogens/cyclic medroxyprogesterone acetate.
    Khoo SK; Coglan M; Battistutta D; Tippett V; Raphael B
    Climacteric; 1998 Mar; 1(1):55-62. PubMed ID: 11907928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide in postmenopausal women taking three different HRT regimens.
    Kesim MD; Aydin Y; Erdemir M; Atis A
    Maturitas; 2005 Jan; 50(1):52-7. PubMed ID: 15590214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The case for hormone replacement: new studies that should inform the debate.
    Thacker HL
    Cleve Clin J Med; 2002 Sep; 69(9):670, 672-3, 677-8. PubMed ID: 12222970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns and correlates of hormone replacement therapy use among middle-aged Australian women.
    France K; Schofield MJ; Lee C
    Womens Health; 1997; 3(2):121-38. PubMed ID: 9332154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of the effect of fluoxetine combined with hormone replacement therapy (HRT) and single HRT in treating menopausal depression].
    Yu Q; Yin CX; Hui Y; Yu J; He FF; Wei J; Wu YY
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):461-4. PubMed ID: 15347469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.
    Nachtigall MJ; Smilen SW; Nachtigall RD; Nachtigall RH; Nachtigall LE
    Obstet Gynecol; 1992 Nov; 80(5):827-30. PubMed ID: 1328978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of exercise training added to ongoing hormone replacement therapy on bone mineral density in frail elderly women.
    Villareal DT; Binder EF; Yarasheski KE; Williams DB; Brown M; Sinacore DR; Kohrt WM
    J Am Geriatr Soc; 2003 Jul; 51(7):985-90. PubMed ID: 12834519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
    Gutteridge DH; Holzherr ML; Retallack RW; Price RI; Will RK; Dhaliwal SS; Faulkner DL; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Drury PJ; Tran L; Bhagat CI; Kent GN; Jamrozik K
    Calcif Tissue Int; 2003 Jul; 73(1):33-43. PubMed ID: 14506952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
    Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changes.
    Nand SL; Webster MA; Wren BG
    Aust N Z J Obstet Gynaecol; 1995 Feb; 35(1):92-6. PubMed ID: 7772012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-menopausal hormone therapy reduces autoantibodies to oxidized apolipoprotein B100.
    Castanho VS; Gidlund M; Nakamura R; de Faria EC
    Gynecol Endocrinol; 2011 Oct; 27(10):800-6. PubMed ID: 21879795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ; Zuckerman IH; Lee E
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Sbarouni E; Kyriakides ZS; Kremastinos DTh
    J Am Coll Cardiol; 1998 Nov; 32(5):1244-50. PubMed ID: 9809932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen plus progestin and risk of venous thrombosis.
    Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
    JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.